Home › Peripheral T-Cell Lymphoma › Georgia › Atlanta
Peripheral T-Cell Lymphoma clinical trials in Atlanta, GA
4 studies for Peripheral T-Cell Lymphoma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Emory University Medical Center, Atlanta
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Emory University, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecruitingPhase 1/2
- Emory Winship Cancer Institute, Atlanta
Peripheral T-Cell Lymphoma trials in other cities
- Houston, TX9 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Baldwin Park, CA5 studies
- Philadelphia, PA4 studies
- Aurora, CO3 studies
- Ann Arbor, MI3 studies
- Columbus, OH3 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia30 studies
- Ovarian Cancer29 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Metastatic Cancer28 studies
- Heart Failure25 studies
- Major Depressive Disorder25 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.